bioRxivDevelopmental BiologyPreprint
SRF is a non-histone methylation target of KDM2B and SET7 in the regulation of myogenesis
Hosouk JoungiD, Joo‐Young KangiD, Jiyoung KimiD, Duk‐Hwa KwoniD, Anna Jeong, Hyun-Ki Min, Sera Shin, Yun-Gyeong Lee, Young‐Kook KimiD, Sang‐Beom SeoiD, Hyun Yi KookiD
Abstract
Demethylation of histone lysines, one of the most important modifications in transcriptional regulation, is associated with various physiological states. KDM2B is a histone H3K4, H3K36, and H3K79 demethylase associated with the repression of transcription. Here, we present a novel mechanism by which KDM2B demethylates serum response factor (SRF) K165 to negatively regulate muscle differentiation, which is counteracted by histone methyltransferase SET7. We show that KDM2B inhibited skeletal muscle differentiation by inhibiting the transcription of SRF-dependent genes. Both KDM2B and SET7 regulated the balance of SRF K165 methylation. SRF K165 methylation was required for the transcriptional activation of SRF and for the promoter occupancy of SRF-dependent genes. SET7 inhibitors blocked muscle cell differentiation. Taken together, these data indicate that SRF is a non-histone target of KDM2B and that the methylation balance of SRF maintained by KDM2B and SET7 plays an important role in muscle cell differentiation.
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- KDM2B is a histone H3K79 demethylase and induces transcriptional repression via SIRT1-mediated chromatin silencing
Joo‐Young Kang, Ji‐Young Kim, … Sang‐Beom Seo·The FASEB JournalPeer-reviewed·May 15, 2018
- SETDB1 modulates the TGFbeta response in Duchenne muscular dystrophy myotubes
A. GRANADOS, M. ZAMPERONI, … S. AIT-SI-ALI·bioRxiv·Jun 28, 2023
- The SMYD3 methyltransferase promotes myogenesis by activating the myogenin regulatory network
R. Codato, M. Perichon, … S. Medjkane·bioRxiv·Oct 16, 2019
- KDM2B controls HIF levels and activity through its JmjC and CxxC domains
Michael Batie, Dilem Shakir, … Sónia Rocha·Biochemical JournalPeer-reviewed·Sep 7, 2026
- SMAD2 promotes myogenin expression and terminal myogenic differentiation.
E. Lamarche, H. AlSudais, … N. Wiper-Bergeron·bioRxiv·Jul 28, 2020
- KDM2B Silencing Elicits a Paracrine Mechanism Which Destabilizes SLUG, Promoting Differentiation of Basal-Like Breast Cancer Cells.
E.-A. Fraile, B. Soysal, … P. N. Tsichlis·bioRxiv·May 21, 2020